Details

NameSymbolSector
OMAXE LIMITEDOMAXEResidential- Commercial Projects
Open
103
High
108.61
Low
95.51
Close
99.14
Volume
18269128
Exchange
nse
Time
14-Aug-2026

Outlook

Score:  

4

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Omaxe is  
Long Body
Estimated Stoploss of Omaxe is ₹  
108.61
Omaxe has a  
Bearishℹ
 pattern. 
Formation of  
Long Body
 candle pattern indicates the trend direction of Omaxe maybe  
Unpredictableℹ
, but keep a lookout for fall in price. 

Trend

Omaxe is in  
Sideways trendℹ
. 
Price of Omaxe is  
Upℹ
 by  

16.09

%. 
Target
Buy @ 

68.88

Sell @ 

96.5

Current @ 

99.14

Volume

The trades of Omaxe have been in  
Immenseℹ
 volume. 
The volume trades for Omaxe are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Omaxe is  

Up

 by  

907.02

% 

Valuation

The current market price of Omaxe is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 14877cr and total assets worth ₹ 14877cr, the balance sheet of Omaxe is:  
Balancedℹ
. 
Cashflow
Omaxe has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 110cr

. It is  
Upℹ
 by  

11100

%. 

(*Mar 2025)

52.92% i.e. ₹ 1006cr earned in operatingℹ
6.58% i.e. ₹ 125cr spent in investingℹ
40.5% i.e. ₹ 770cr spent in financingℹ
0% in otherℹ
Omaxe has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 1cr

. It is  
Downℹ
 by  

101.54

%. 

(*Mar 2024)

49.95% i.e. ₹ 986cr earned in operatingℹ
3.24% i.e. ₹ 64cr spent in investingℹ
46.81% i.e. ₹ 924cr spent in financingℹ
0% in otherℹ
Income
The income of Omaxe is  

₹ 346cr

 and  

Loss

 is :  

₹ 166cr

(*Sep 2025)

Omaxe Losses decreased by:  

10.27

% and Income is Up by:  

16.11

% 

(*Sep 2025)

The income of Omaxe is  

₹ 298cr

 and  

Loss

 is :  

₹ 185cr

(*Jun 2025)

Omaxe Losses increased by:  

25

% and Income is Down by:  

46.11

% 

(*Jun 2025)

The income of Omaxe is  

₹ 553cr

 and  

Loss

 is :  

₹ 148cr

(*Mar 2025)

Omaxe Losses decreased by:  

1.33

% and Income is Up by:  

84.33

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.